Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot
Germany
Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
<Goal xmlns="http://hl7.org/fhir">
<id value="DiagnosticGoal"/>
<meta>
<profile
value="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-goal"/>
</meta>
<language value="de"/>
<text>
<status value="extensions"/>
<div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Goal DiagnosticGoal</b></p><a name="DiagnosticGoal"> </a><a name="hcDiagnosticGoal"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-onko-therapy-goal.html">Onkologisches Therapieziel</a></p></div><blockquote><p><b>Goal acceptance</b></p><ul><li>individual: <a href="Patient-PatientinMamma.html">Sabine Baumann Female, DoB: 1977-06-24</a></li><li>status: agree</li><li>priority: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-priority high-priority}">High Priority</span></li></ul></blockquote><p><b>lifecycleStatus</b>: Active</p><p><b>achievementStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-achievement in-progress}">In Progress</span></p><p><b>category</b>: <span title="Codes:{http://snomed.info/sct 261004008}">Diagnostic intent</span></p><p><b>priority</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/goal-priority high-priority}">High Priority</span></p><p><b>description</b>: <span title="Codes:">Diagnosesicherung für die Verdachtsdiagnose</span></p><p><b>subject</b>: <a href="Patient-PatientinMamma.html">Sabine Baumann Female, DoB: 1977-06-24</a></p><p><b>start</b>: 2025-09-12</p><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21905-5}">Primary tumor.clinical [Class] Cancer</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21906-3}">Regional lymph nodes.clinical [Class] Cancer</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21907-1}">Distant metastases.clinical [Class] Cancer</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21908-9}">Stage group.clinical Cancer</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 40556-3}">Estrogen receptor Ag [Presence] in Tissue by Immune stain</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 85339-0}">Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 48676-1}">HER2 Ag [Interpretation] in Tissue</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 21855-2}">Primary site Cancer</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 44648-4}">Histologic grade [Score] in Breast cancer specimen by Nottingham</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 33732-9}">Histology grade [Identifier] in Cancer specimen</span></p></blockquote><blockquote><p><b>target</b></p><p><b>measure</b>: <span title="Codes:{http://loinc.org 85347-3}">Sentinel lymph nodes examined [#] in Cancer specimen by Light microscopy</span></p></blockquote><p><b>expressedBy</b>: <a href="Practitioner-OnkologinMamma.html">Practitioner Katrin Musterarzt </a></p><p><b>addresses</b>: <a href="Condition-ConditionMamma.html">Condition Bösartige Neubildung: Oberer äußerer Quadrant der Brustdrüse</a></p><p><b>outcomeReference</b>: <a href="Observation-ObsDiseaseStatusMamma.html">Observation Cancer disease progression</a></p></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/goal-acceptance">
<extension url="individual">
<valueReference>🔗
<reference value="Patient/PatientinMamma"/>
</valueReference>
</extension>
<extension url="status">
<valueCode value="agree"/>
</extension>
<extension url="priority">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/goal-priority"/>
<code value="high-priority"/>
<display value="High Priority"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
<lifecycleStatus value="active"/>
<achievementStatus>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/goal-achievement"/>
<code value="in-progress"/>
<display value="In Progress"/>
</coding>
</achievementStatus>
<category>
<coding>
<system value="http://snomed.info/sct"/>
<code value="261004008"/>
<display value="Diagnostic intent"/>
</coding>
</category>
<priority>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/goal-priority"/>
<code value="high-priority"/>
<display value="High Priority"/>
</coding>
</priority>
<description>
<text value="Diagnosesicherung für die Verdachtsdiagnose"/>
</description>
<subject>🔗
<reference value="Patient/PatientinMamma"/>
</subject>
<startDate value="2025-09-12"/>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21905-5"/>
<display value="Primary tumor.clinical [Class] Cancer"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21906-3"/>
<display value="Regional lymph nodes.clinical [Class] Cancer"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21907-1"/>
<display value="Distant metastases.clinical [Class] Cancer"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21908-9"/>
<display value="Stage group.clinical Cancer"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="40556-3"/>
<display
value="Estrogen receptor Ag [Presence] in Tissue by Immune stain"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="85339-0"/>
<display
value="Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="48676-1"/>
<display value="HER2 Ag [Interpretation] in Tissue"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="21855-2"/>
<display value="Primary site Cancer"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="44648-4"/>
<display
value="Histologic grade [Score] in Breast cancer specimen by Nottingham"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="33732-9"/>
<display value="Histology grade [Identifier] in Cancer specimen"/>
</coding>
</measure>
</target>
<target>
<measure>
<coding>
<system value="http://loinc.org"/>
<code value="85347-3"/>
<display
value="Sentinel lymph nodes examined [#] in Cancer specimen by Light microscopy"/>
</coding>
</measure>
</target>
<expressedBy>🔗
<reference value="Practitioner/OnkologinMamma"/>
</expressedBy>
<addresses>🔗
<reference value="Condition/ConditionMamma"/>
</addresses>
<outcomeReference>🔗
<reference value="Observation/ObsDiseaseStatusMamma"/>
</outcomeReference>
</Goal>